BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26226096)

  • 1. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
    Hatlebakk JG; Zerbib F; Bruley des Varannes S; Attwood SE; Ell C; Fiocca R; Galmiche JP; Eklund S; Långström G; Lind T; Lundell LR;
    Clin Gastroenterol Hepatol; 2016 May; 14(5):678-85.e3. PubMed ID: 26226096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial.
    Galmiche JP; Hatlebakk J; Attwood S; Ell C; Fiocca R; Eklund S; Långström G; Lind T; Lundell L;
    JAMA; 2011 May; 305(19):1969-77. PubMed ID: 21586712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect on symptoms and quality of life of maintenance therapy with esomeprazole 20 mg daily: a post hoc analysis of the LOTUS trial.
    Lundell L; Hatlebakk J; Galmiche JP; Attwood SE; Ell C; Fiocca R; Persson T; Nagy P; Eklund S; Lind T
    Curr Med Res Opin; 2015 Jan; 31(1):65-73. PubMed ID: 25350223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease.
    Omari T; Davidson G; Bondarov P; Nauclér E; Nilsson C; Lundborg P
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S2-8. PubMed ID: 26422094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease.
    Omari T; Davidson G; Bondarov P; Nauclér E; Nilsson C; Lundborg P
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S2-8. PubMed ID: 26121346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
    Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
    Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial.
    Fiocca R; Mastracci L; Engström C; Attwood S; Ell C; Galmiche JP; Hatlebakk J; Junghard O; Lind T; Lundell L;
    Am J Gastroenterol; 2010 May; 105(5):1015-23. PubMed ID: 19904246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus.
    Yeh RW; Gerson LB; Triadafilopoulos G
    Dis Esophagus; 2003; 16(3):193-8. PubMed ID: 14641308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
    Peng S; Xiong LS; Xiao YL; Wang AJ; Lin JK; Hu PJ; Chen MH
    Chin Med J (Engl); 2010 Aug; 123(15):2012-7. PubMed ID: 20819534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal mucosal integrity improves after laparoscopic antireflux surgery in children with gastroesophageal reflux disease.
    Mauritz FA; Rinsma NF; van Heurn ELW; Sloots CEJ; Siersema PD; Houwen RHJ; van der Zee DC; Masclee AAM; Conchillo JM; Van Herwaarden-Lindeboom MYA
    Surg Endosc; 2017 Jul; 31(7):2910-2917. PubMed ID: 27804042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
    Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
    J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of antireflux treatment on the frequency of awakenings from sleep in patients with Gastroesophageal reflux disease.
    Jha LK; Maradey-Romero C; Gadam R; Hershcovici T; Fass OZ; Quan SF; Guillen J; Fass R
    Neurogastroenterol Motil; 2015 Feb; 27(2):237-45. PubMed ID: 25484104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder.
    Kaufman JA; Houghland JE; Quiroga E; Cahill M; Pellegrini CA; Oelschlager BK
    Surg Endosc; 2006 Dec; 20(12):1824-30. PubMed ID: 17063301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial on endoscopic full-thickness gastroplication versus laparoscopic antireflux surgery in GERD patients without hiatal hernias.
    Kaindlstorfer A; Koch OO; Antoniou SA; Asche KU; Granderath FA; Pointner R
    Surg Laparosc Endosc Percutan Tech; 2013 Apr; 23(2):212-22. PubMed ID: 23579521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The impact of proton pump inhibitors on esophageal acid exposure in gastroesophageal reflux disease].
    Liang XY; Chen WN; Lan L; Wang Q; Lü YW; Lan Y
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):513-5. PubMed ID: 22943821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GERD assessment including pH metry predicts a high response rate to PPI standard therapy.
    Kandulski A; Peitz U; Mönkemüller K; Neumann H; Weigt J; Malfertheiner P
    BMC Gastroenterol; 2013 Jan; 13():12. PubMed ID: 23324360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of laparoscopic antireflux surgery on belching in pediatric GERD patients.
    Rinsma NF; Mauritz FA; van Heurn LW; Sloots CE; Siersema PD; Houwen RH; van der Zee DC; Masclee AA; Conchillo JM; Van Herwaarden-Lindeboom MY
    Neurogastroenterol Motil; 2016 Oct; 28(10):1525-32. PubMed ID: 27151185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgery.
    Mastracci L; Fiocca R; Engström C; Attwood S; Ell C; Galmiche JP; Hatlebakk JG; Långström G; Eklund S; Lind T; Lundell L
    Aliment Pharmacol Ther; 2017 May; 45(10):1339-1349. PubMed ID: 28326569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal study of gastroesophageal reflux and erosive tooth wear.
    Wilder-Smith CH; Materna A; Martig L; Lussi A
    BMC Gastroenterol; 2017 Oct; 17(1):113. PubMed ID: 29070010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.